CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+7.66%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$373M
AUM Growth
+$373M
(-14%)
Cap. Flow
-$46.3M
Cap. Flow
% of AUM
-12.42%
Top 10 Holdings %
Top 10 Hldgs %
44.78%
Holding
63
New
17
Increased
9
Reduced
13
Closed
10
Top Buys
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$18.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$17.2M |
| 3 |
Akebia Therapeutics
AKBA
|
$11.1M |
| 4 |
Omeros
OMER
|
$10.8M |
| 5 |
Heron Therapeutics
HRTX
|
$8.62M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$38.6M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$21.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$20.5M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$16.5M |
| 5 |
IDIX
IDENIX PHARMACEUTICALS INC
IDIX
|
$15.1M |
Sector Composition
| 1 | Healthcare | 78.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Curis
CRIS
$21.5M
| $1.12M | 0.3% |
+6,000
| New | +$1.12M |
|
52
SCYNEXIS
SCYX
$35.2M
| $802K | 0.21% |
+10,000
| New | +$802K |
|
|
AKTX
53
Akari Therapeutics
AKTX
$21.4M
| $639K | 0.17% |
515
| – | – |
|
54
Biogen
BIIB
$20.5B
| – | – |
-10,000
| Closed | -$3.06M |
|
|
55
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-300,000
| Closed | -$20.5M |
|
56
Geron
GERN
$893M
| – | – |
-1,587,000
| Closed | -$3.14M |
|
57
Pacira BioSciences
PCRX
$1.22B
| – | – |
-50,000
| Closed | -$3.5M |
|
58
Prothena Corp
PRTA
$452M
| – | – |
-350,000
| Closed | -$13.4M |
|
|
ICPT
59
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-50,000
| Closed | -$16.5M |
|
|
ACGN
60
DELISTED
Aceragen, Inc. Common Stock
ACGN
| – | – |
-2,944
| Closed | -$1.63M |
|
|
CBST
61
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| – | – |
-300,000
| Closed | -$21.9M |
|
|
IDIX
62
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| – | – |
-2,500,000
| Closed | -$15.1M |
|
|
MDVN
63
DELISTED
MEDIVATION, INC.
MDVN
| – | – |
-1,200,000
| Closed | -$38.6M |
|